Drugs.com: More naloxone orders filled when pharmacists can dispense
UC research on naloxone dispensing makes headlines across the country
Pharmacy researchers at the University of Cincinnati unveiled an impactful research study on Jan. 31, 2020 that shows an association between a 2015 Ohio law and a surge in the dispensing of naloxone in Ohio pharmacies. Naloxone is the anti-overdose drug and pharmacists here can now legally dispense it in the state, without a prescription.
While the study focused solely on the increase in distribution of this lifesaving medication, the implications are that death rates by overdose drop up to 14% in states where access is increased. As the opioid crisis continues to plague the U.S. and other countries, reporters from national, regional and local outlets took great interest in the study. The college dean, Neil MacKinnon, and lead faculty researcher, Pamela Heaton, participated in both televsion and print media interviews within days of the study's release.
A sample of the widespread interest includes:
- USA Today: News from around our 50 states
- Drugs.com: More Naloxone Orders Filled When Pharmacists Can Dispense
- U.S. News and World Report: Study: Naloxone Dispensing Increased More Than 2,000%
- AP: Study: Naloxone dispensing increased more than 2,000%
- UPI: Naloxone sales up 2,300% in Ohio after law loosens pharmacist restrictions
- WBNS: Study: Naloxone dispensing in Ohio increased more than 2,000% since 2015
Featured image: generic pharmacy purchases/unsplash.com/Tbel Abuseridze
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.